Making an Impact on Hit Triage
Researchers are using phenotypic assays at earlier and earlier stages of drug discovery. Assays for…
Researchers are using phenotypic assays at earlier and earlier stages of drug discovery. Assays for…
Where are we with validation of assays to replace animals for product testing? The short…
Drug discovery practitioners are painfully familiar with “nuisance” compounds. These compounds may be screening hits…
Quietly happening beneath the radar, phenotypic platforms are becoming integrated into drug discovery processes. Why…
A recent paper from NTP showcases the application of mechanism-based NAMs for prediction of cardiotoxic…
Has FDA lost it’s way with NAMs? NAMs or New Alternative Methodologies is the term…
It takes courage to address common pitfalls in drug discovery and perseverance to traverse the…
Is coronavirus morbidity exacerbated by environmental pollution? A potential mechanism underlying thrombosis-related side effects connects…
How can we incorporate human-based animal alternatives into drug discovery? Can we reduce animal testing…
A strong chain of translatability is crucial for successful drug discovery programs. The chain of…